A Trial of Patients With a Charles Bonnet Syndrome
- Conditions
- Prevalence, Psychiatrist Intervention
- Interventions
- Other: interview
- Registration Number
- NCT03148249
- Lead Sponsor
- Vienna Institute for Research in Ocular Surgery
- Brief Summary
Charles Bonnet Syndrome (CBS) is defined by the occurence of visual hallucinations (VH) in the absence of any mental disorder. Elderly patients with reduced visual acuity due to ophthalmic diseases are most affected. Conditions are often associated with the syndrome of age-related macular degeneration, cataract or glaucoma. Existing data on the syndrome's prevalence in Europe reveal diverse results. Aim of this study was to assess the prevalence of CBS in patients with low visual acuity and to evaluate, if an additional therapeutic interview with and treatment by a psychiatrist is beneficial.
- Detailed Description
Patients with a visual acuity of 0.5 LogMAR or less in the better eye were screened for CBS. Instruments used were an interview asking for details of the hallucinations, a mental test and a scale concerning quality of life. Patients with CBS were randomized by minimization in two groups: in group 1, a patient-doctor interview by an ophthalmologist was performed and in group 2 an interview and if needed, a therapy by a psychiatrist. At the 3-months follow up, the psychological strain of patients was recorded again.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
- written informed consent
- visual acuity of 0.5 LogMAR or less at both eyes
- 55 years or older
Patients with CBS:
- have no mental pathologies such as dementia, psychosis or any other neurological diseases
- have a normal cognitive state
- are not able to control the VH
- know that the VH are not real
- are usually older
- have significantly reduced visual acuity due to an bilateral eye pathology
VH associated with CBS:
- disappear when the eyes are closed
- are repetitive
- are complex (eg. objects, geometrical patterns, faces, shapes, figures, scenes, animals or plants)
- dopamine agonist medication
- temporal lobe epilepsy
- moderate to severe Alzheimer's dementia
- present chronic alcohol-/drug abuse
- bad cognitive state
There are no:
- auditory or olfactory hallucinations
- other abnormalities like delusions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description interview with an ophthalmologist interview Patients get an interview with an ophthalmologist interview/treatment by a psychiatrist interview patients get an interview and a possible treatment by a psychiatrist
- Primary Outcome Measures
Name Time Method Quality of life score between the two groups 3 months Quality of life score between the study and control group
- Secondary Outcome Measures
Name Time Method